72 related articles for article (PubMed ID: 23728705)
1. Clinical potential of the anticancer drug sensitivity test for patients with synchronous stage IV colorectal cancer.
Takebayashi K; Mekata E; Sonoda H; Shimizu T; Endo Y; Tani T
Cancer Chemother Pharmacol; 2013 Jul; 72(1):217-22. PubMed ID: 23728705
[TBL] [Abstract][Full Text] [Related]
2. In vitro-chemosensitivity test using the collagen gel droplet embedded culture drug test (CD-DST) for malignant pleural mesothelioma: possibility of clinical application.
Higashiyama M; Oda K; Okami J; Maeda J; Kodama K; Takami K; Morinaga K; Takano T; Kobayashi H
Ann Thorac Cardiovasc Surg; 2008 Dec; 14(6):355-62. PubMed ID: 19131921
[TBL] [Abstract][Full Text] [Related]
3. Clinical applications of the histoculture drug response assay.
Furukawa T; Kubota T; Hoffman RM
Clin Cancer Res; 1995 Mar; 1(3):305-11. PubMed ID: 9815986
[TBL] [Abstract][Full Text] [Related]
4. Prediction of chemotherapeutic effect on postoperative recurrence by in vitro anticancer drug sensitivity testing in non-small cell lung cancer patients.
Higashiyama M; Oda K; Okami J; Maeda J; Kodama K; Imamura F; Minamikawa K; Takano T; Kobayashi H
Lung Cancer; 2010 Jun; 68(3):472-7. PubMed ID: 19660825
[TBL] [Abstract][Full Text] [Related]
5. Repeated hepatic intra-arterial chemotherapy based on results of anticancer drug sensitivity test in patients with synchronous hepatic metastases from colorectal cancer.
Matsuoka H; Nagaya M; Tsukikawa S; Yanagi Y; Isogai A; Kubota S
Surgery; 2006 Sep; 140(3):387-95. PubMed ID: 16934600
[TBL] [Abstract][Full Text] [Related]
6. Clinical evaluation of chemosensitivity testing for patients with unresectable non-small cell lung cancer (NSCLC) using collagen gel droplet embedded culture drug sensitivity test (CD-DST).
Kawamura M; Gika M; Abiko T; Inoue Y; Oyama T; Izumi Y; Kobayashi H; Kobayashi K
Cancer Chemother Pharmacol; 2007 Mar; 59(4):507-13. PubMed ID: 16896928
[TBL] [Abstract][Full Text] [Related]
7. An anticancer drug sensitivity test to determine the effectiveness of UFT as postoperative adjuvant chemotherapy for patients with stage III colorectal cancer.
Isogai A; Nagaya M; Matsuoka H; Watanabe T; Tsukikawa S; Kubota S
Surgery; 2007 Nov; 142(5):741-8. PubMed ID: 17981195
[TBL] [Abstract][Full Text] [Related]
8. In vitro drug testing of ovarian cancer using the human tumor colony-forming assay: comparison of in vitro response and clinical outcome.
Federico M; Alberts DS; Garcia DJ; Emerson J; Fanta P; Liu R; Salmon SE
Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S156-63. PubMed ID: 7835801
[TBL] [Abstract][Full Text] [Related]
9. In vitro drug responses in primary and metastatic colorectal cancers.
Mechetner E; Brünner N; Parker RJ
Scand J Gastroenterol; 2011 Jan; 46(1):70-8. PubMed ID: 20695724
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapy-induced suppression to adenoma or complete suppression of the primary in patients with stage IV colorectal cancer: report of four cases.
Armbrust T; Sobotta M; Füzesi L; Grabbe E; Ramadori G
Eur J Gastroenterol Hepatol; 2007 Nov; 19(11):988-94. PubMed ID: 18049169
[TBL] [Abstract][Full Text] [Related]
11. Use of the collagen gel droplet embedded drug sensitivity test to determine drug sensitivity against ovarian mature cystic teratoma with malignant transformation to adenocarcinoma: a case report.
Yamagami W; Banno K; Kawaguchi M; Yanokura M; Kuwabara Y; Hirao N; Susumu N; Tsukazaki K; Aoki D
Chemotherapy; 2007; 53(2):137-41. PubMed ID: 17308380
[TBL] [Abstract][Full Text] [Related]
12. Bevacizumab in combination with chemotherapy in the first-line treatment of metastatic colorectal carcinoma.
Usakova V; Sevcikova K; Usak J; Bartosova Z; Mikulova M; Spanik S
Neoplasma; 2013; 60(1):83-91. PubMed ID: 23067221
[TBL] [Abstract][Full Text] [Related]
13. Survival of patients with limited-stage small cell lung cancer treated with individualized chemotherapy selected by in vitro drug sensitivity testing.
Cortazar P; Gazdar AF; Woods E; Russell E; Steinberg SM; Williams J; Ihde DC; Johnson BE
Clin Cancer Res; 1997 May; 3(5):741-7. PubMed ID: 9815744
[TBL] [Abstract][Full Text] [Related]
14. Relationships between the expression of thymidylate synthase, dihydropyrimidine dehydrogenase, and orotate phosphoribosyltransferase and cell proliferative activity and 5-fluorouracil sensitivity in colorectal carcinoma.
Fujii R; Seshimo A; Kameoka S
Int J Clin Oncol; 2003 Apr; 8(2):72-8. PubMed ID: 12720098
[TBL] [Abstract][Full Text] [Related]
15. Macrophage inflammatory protein-3 alpha (MIP-3a) is a novel serum prognostic marker in patients with colorectal cancer.
Iwata T; Tanaka K; Inoue Y; Toiyama Y; Hiro J; Fujikawa H; Okugawa Y; Uchida K; Mohri Y; Kusunoki M
J Surg Oncol; 2013 Feb; 107(2):160-6. PubMed ID: 22926691
[TBL] [Abstract][Full Text] [Related]
16. High epidermal growth factor receptor expression in metastatic colorectal cancer lymph nodes may be more prognostic of poor survival than in primary tumor.
Deng Y; Kurland BF; Wang J; Bi J; Li W; Rao S; Lan P; Lin T; Lin E
Am J Clin Oncol; 2009 Jun; 32(3):245-52. PubMed ID: 19451802
[TBL] [Abstract][Full Text] [Related]
17. Capecitabine and oxaliplatin (XELOX) as first-line treatment for patients with metastatic colorectal cancer.
Karacetin D; Yalcin B; Okten B; Ozturk S; Maral O; Incekara O
J BUON; 2009; 14(4):605-8. PubMed ID: 20148449
[TBL] [Abstract][Full Text] [Related]
18. Correlation of drug response with the ATP tumorchemosensitivity assay in primary FIGO stage III ovarian cancer.
Konecny G; Crohns C; Pegram M; Felber M; Lude S; Kurbacher C; Cree IA; Hepp H; Untch M
Gynecol Oncol; 2000 May; 77(2):258-63. PubMed ID: 10785475
[TBL] [Abstract][Full Text] [Related]
19. Clinical impact of K-ras mutation in colorectal cancer patients treated with adjuvant FOLFOX.
Chang MH; Lee IK; Si Y; Lee KS; Woo IS; Byun JH
Cancer Chemother Pharmacol; 2011 Aug; 68(2):317-23. PubMed ID: 20972872
[TBL] [Abstract][Full Text] [Related]
20. Response to neoadjuvant chemotherapy does not predict overall survival for patients with synchronous colorectal hepatic metastases.
Gallagher DJ; Zheng J; Capanu M; Haviland D; Paty P; Dematteo RP; D'Angelica M; Fong Y; Jarnagin WR; Allen PJ; Kemeny N
Ann Surg Oncol; 2009 Jul; 16(7):1844-51. PubMed ID: 19224284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]